Post #23890

U.S. listed company Sonnet will merge to form Hyperliquid Strategies and launch a Treasury Reserve Strategy holding 12.6 million HYPE tokens and $3 billion in cash. According to The Block, Nasdaq-listed company Sonnet BioTherapeutics has agreed to an $8.88 billion merger deal, will be renamed Hyperliquid Strategies, and will launch the HYPE treasury strategy. The Nasdaq-listed company Sonnet BioTherapeutics has agreed to merge with Rorschach I LLC to form Hyperliquid Strategies and launch a treasury strategy. According to a press release issued on Monday, Rorschach I LLC is a newly formed company by affiliated entities of Atlas Merchant Capital LLC, companies affiliated with Paradigm Operations LP, and other sponsors. 📱@Money📱Twitter